This week from Drug Target Review...

This week from Drug Target Review...

OUR EVENT IS LIVE!

Last chance to register for our online summit on the development of next-generation vaccines. Bringing you exclusive knowledge and unparalleled networking opportunities at the touch of a button over the next two-days! Registration takes less than a minute!

No alt text provided for this image

Busy this week? Don’t worry, access to our content will be available on-demand for 12 months to watch at your leisure.

REGISTER NOW

EDITOR'S PICK

Ultra-powerful brain scanners offer hope for treating cognitive symptoms in Parkinson’s disease

No alt text provided for this image

Ultra-powerful 7T MRI scanners could be used to help identify those patients with Parkinson’s disease and similar conditions most likely to benefit from new treatments for previously untreatable symptoms.

READ MORE

NEWS

Novel process revolutionises microfluidic fabrication

Researchers have implemented structural colour printing in microfluidic fabrication which creates new pathways for medical diagnostics and miniaturised sensors.

Thanks to existing vaccines, monkeypox could be containable

Governments outside of Africa have launched limited vaccinations to fight against the rising number of monkeypox cases.

Novel machine learning technique to develop new drugs

New machine learning models could propose new molecules that have specific properties which could fight certain diseases, doing in minutes what might take humans months to achieve manually.

Grant awarded to research centre to create lab-on-a-chip technology

A research centre based at the University of Kansas has been awarded $6.6 million to create lab-on-a-chip technology for medical tests.

Drug repurposed to boost functional recovery after a stroke

A drug currently prescribed to control seizures and reduce nerve pain may enhance recovery of movement after a stroke.

WHAT TO LISTEN TO

Tune in to our podcast series on the latest information in the drug discovery industry, from cell line development to SARS-CoV-2 variants - and everything in between!?

LISTEN NOW

Follow us on?Spotify,?Apple?and?Google?to be the first to know when a new episode is published!

JOIN THE COMMUNITY

Sign up to our?FREE?journal?for information on the drug discovery industry; promoting the latest research and developments, funding projects, and cutting-edge technological developments, as well as access to:

  • Quarterly issues in print or digital format
  • Breaking news and features on our website
  • Case studies, whitepapers, webinars and industry-leading content
  • Our extensive online archive of thousands of articles and past issues.

SUBSCRIBE FREE TODAY

No alt text provided for this image

Want to keep up to date with our latest content? Follow us on?Want to keep up to date with our latest content? Follow us on?LinkedIn,?Facebook,?Twitter?and?YouTube.

要查看或添加评论,请登录

Drug Target Review的更多文章

社区洞察

其他会员也浏览了